RBM5 Reduces Small Cell Lung Cancer Growth, Increases Cisplatin Sensitivity and Regulates Key Transformation-associated Pathways

Overview

Journal Heliyon

Specialty Social Sciences

Date 2016 Dec 14

PMID 27957556

Citations 11

Authors

Julie J Loiselle

Justin G Roy

Leslie C Sutherland

Affiliations

Soon will be listed here.

Abstract

Small cell lung cancer (SCLC) is the most aggressive type of lung cancer, with almost 95% of patients succumbing to the disease. Although , a tumor suppressor gene, is downregulated in the majority of lung cancers, its role in SCLC is unknown. Using the GLC20 SCLC cell line, which has a homozygous deletion encompassing the gene locus, we established stable expressing sublines and investigated the effects of re-expression. Transcriptome and target identification studies determined that RBM5 directly regulates the cell cycle and apoptosis in SCLC cells, as well as significantly downregulates other important transformation-associated pathways such as angiogenesis and cell adhesion. RNA sequencing of paired non-tumor and tumor SCLC patient specimens showed decreased expression in the tumors, and expression alterations in the majority of the same pathways that were altered in the GLC20 cells and sublines. Functional studies confirmed expression slows SCLC cell line growth, and increases sensitivity to the chemotherapy drug cisplatin. Overall, our work demonstrates the importance of expression to the non-transformed state of lung cells and the consequences of its deletion to SCLC development and progression.

Citing Articles

RBM47 promotes cell proliferation and immune evasion by upregulating PDIA6: a novel mechanism of pancreatic cancer progression.

Ma Y, Liu E, Fan H, Li C, Huang P, Cui M J Transl Med. 2024; 22(1):1164.

PMID: 39741300 PMC: 11687039. DOI: 10.1186/s12967-024-05970-6.

RNA binding proteins in cancer chemotherapeutic drug resistance.

Vembuli H, Gor R, Ramalingam S, Perales S, Rajasingh J Front Cell Dev Biol. 2024; 12:1308102.

PMID: 38328550 PMC: 10847363. DOI: 10.3389/fcell.2024.1308102.

The RNA-Binding Motif Protein Family in Cancer: Friend or Foe?.

Li Z, Guo Q, Zhang J, Fu Z, Wang Y, Wang T Front Oncol. 2021; 11:757135.

PMID: 34804951 PMC: 8600070. DOI: 10.3389/fonc.2021.757135.

Exploiting the potential of commercial digital holographic microscopy by combining it with 3D matrix cell culture assays.

Hellesvik M, Oye H, Aksnes H Sci Rep. 2020; 10(1):14680.

PMID: 32895419 PMC: 7477226. DOI: 10.1038/s41598-020-71538-1.

RNA Binding Motif 5 (RBM5) in the CNS-Moving Beyond Cancer to Harness RNA Splicing to Mitigate the Consequences of Brain Injury.

Jackson T, Kochanek P Front Mol Neurosci. 2020; 13:126.

PMID: 32765218 PMC: 7381114. DOI: 10.3389/fnmol.2020.00126.

References

Jain R, DeVine T, George A, Chittur S, Baroni T, Penalva L . RIP-Chip analysis: RNA-Binding Protein Immunoprecipitation-Microarray (Chip) Profiling. Methods Mol Biol. 2010; 703:247-63. DOI: 10.1007/978-1-59745-248-9_17. View

Abreu A, Dauber A, Macedo D, Noel S, Brito V, Gill J . Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013; 368(26):2467-75. PMC: 3808195. DOI: 10.1056/NEJMoa1302160. View

Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A . Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006; 24(28):4539-44. DOI: 10.1200/JCO.2005.04.4859. View

Li P, Wang K, Zhang J, Zhao L, Liang H, Shao C . The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin. Cancer Epidemiol. 2012; 36(5):481-9. DOI: 10.1016/j.canep.2012.04.004. View

Guallar D, Wang J . RNA-binding proteins in pluripotency, differentiation, and reprogramming. Front Biol (Beijing). 2015; 9(5):389-409. PMC: 4279953. DOI: 10.1007/s11515-014-1326-y. View

Rappa G, Green T, Karbanova J, Corbeil D, Lorico A . Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget. 2015; 6(10):7970-91. PMC: 4480729. DOI: 10.18632/oncotarget.3419. View

Kok K, van den Berg A, Veldhuis P, van der Veen A, Franke M, Schoenmakers E . A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes. Cancer Res. 1994; 54(15):4183-7. View

Unni A, Lockwood W, Zejnullahu K, Lee-Lin S, Varmus H . Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma. Elife. 2015; 4:e06907. PMC: 4478584. DOI: 10.7554/eLife.06907. View

Su Z, Wang K, Li R, Yin J, Hao Y, Lv X . Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells. World J Surg Oncol. 2016; 14:57. PMC: 4770605. DOI: 10.1186/s12957-016-0815-7. View

10.

Jeon W, Hong H, Seo W, Lim K, Lee H, Kim W . Smad7 sensitizes A549 lung cancer cells to cisplatin-induced apoptosis through heme oxygenase-1 inhibition. Biochem Biophys Res Commun. 2012; 420(2):288-92. DOI: 10.1016/j.bbrc.2012.02.151. View

11.

Trapnell C, Hendrickson D, Sauvageau M, Goff L, Rinn J, Pachter L . Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 2012; 31(1):46-53. PMC: 3869392. DOI: 10.1038/nbt.2450. View

12.

Oh J, West A, Fishbein M, Slamon D . A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3. Cancer Res. 2002; 62(11):3207-13. View

13.

Trapnell C, Williams B, Pertea G, Mortazavi A, Kwan G, van Baren M . Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010; 28(5):511-5. PMC: 3146043. DOI: 10.1038/nbt.1621. View

14.

Ramaswamy S, Ross K, Lander E, Golub T . A molecular signature of metastasis in primary solid tumors. Nat Genet. 2002; 33(1):49-54. DOI: 10.1038/ng1060. View

15.

Gupta A, Nitoiu D, Brennan-Crispi D, Addya S, Riobo N, Kelsell D . Cell cycle- and cancer-associated gene networks activated by Dsg2: evidence of cystatin A deregulation and a potential role in cell-cell adhesion. PLoS One. 2015; 10(3):e0120091. PMC: 4364902. DOI: 10.1371/journal.pone.0120091. View

16.

Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M . Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2013; 42(Database issue):D199-205. PMC: 3965122. DOI: 10.1093/nar/gkt1076. View

17.

Yabas M, Jing W, Shafik S, Broer S, Enders A . ATP11C Facilitates Phospholipid Translocation across the Plasma Membrane of All Leukocytes. PLoS One. 2016; 11(1):e0146774. PMC: 4723305. DOI: 10.1371/journal.pone.0146774. View

18.

. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014; 511(7511):543-50. PMC: 4231481. DOI: 10.1038/nature13385. View

19.

Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley D . Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012; 7(3):562-78. PMC: 3334321. DOI: 10.1038/nprot.2012.016. View

20.

Sehgal L, Mathur R, Braun F, Wise J, Berkova Z, Neelapu S . FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia. 2014; 28(12):2376-87. PMC: 5827933. DOI: 10.1038/leu.2014.126. View